Suggested from 4 outlets (1 usually left of the middle, 1 middle, 2 right of it): the fullest account of the event, no political position was found in its wording and its publisher is declared as reporting rather than commentary.
What happened
The outlets' own sentences, most widely reported first. Hover or tap one to see who reported it.
Pancreatic cancer is notoriously difficult to treat, because more than half of patients are diagnosed after the disease has already spread, research shows.
What each outlet says
One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.
Experts are heralding a daily pill called daraxonrasib as a major breakthrough in pancreatic cancer treatment, with some patients showing undetectable tumors on scans. In a trial involving 61 recently diagnosed patients with advanced pancreatic cancer, tumors stopped growing in 90% of participants, and for around 8%, or one in 12, tumors became undetectable. While this is considered highly promising, doctors…
Massive hope for pancreatic cancer pill after trial saw tumours vanish →Doctors are celebrating early results from a trial of a new pill called daraxonrasib for pancreatic cancer, which showed that in one in 12 patients, the cancer became undetectable. In the trial involving 61 patients with advanced cancer that had spread, tumours stopped growing in 90% of cases, and over 60% saw their tumours shrink or disappear. Dr. Wungki Park, who presented the findings at a symposium in Barcelona…
Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’ →A new treatment for pancreatic cancer, involving the drug daraxonrasib combined with chemotherapy, has shown unprecedented results in clinical trials. In these trials, the combination therapy caused tumors to stop growing or shrink significantly, with some tumors becoming undetectable. Specifically, 8.2% of patients had no trace of cancer by the end of the study, and more than 76% of participants survived for at…
‘Massive breakthrough’ as new pancreatic cancer treatment can make tumors disappear: ‘We’ve never seen such a thing’ →A new drug combination involving an experimental pill called daraxonrasib and standard chemotherapy has shown promising results in treating advanced pancreatic cancer. In a phase 1/2 trial presented at the EORTC-NCI-AACR Symposium in Barcelona, this combination shrank tumors or halted their growth in 90.2% of 61 patients, with 60.7% experiencing tumor shrinkage, including 8.2% who saw complete response. The median…
New drug combo shrinks tumors in most patients facing aggressive cancer type →Analysis
Framing
How the first headlines put it
The headlines (3)
Massive hope for pancreatic cancer pill after trial saw tumours vanish
Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’
‘Massive breakthrough’ as new pancreatic cancer treatment can make tumors disappear: ‘We’ve never seen such a thing’
How it changed
- 20 Nov
Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK.
Coverage 4 articles
21 Nov New drug combo shrinks tumors in most patients facing aggressive cancer typeA new drug combination involving an experimental pill called daraxonrasib and standard chemotherapy has shown promising results in treating advanced pancreatic cancer. In a phase 1/2 trial presented at the EORTC-NCI-AACR Symposium in Barcelona, this combination shrank tumors or halted their growth in 90.2% of 61 patients, with 60.7% experiencing tumor shrinkage, including 8.2% who saw complete response. The median…Fox News
20 Nov ‘Massive breakthrough’ as new pancreatic cancer treatment can make tumors disappear: ‘We’ve never seen such a thing’A new treatment for pancreatic cancer, involving the drug daraxonrasib combined with chemotherapy, has shown unprecedented results in clinical trials. In these trials, the combination therapy caused tumors to stop growing or shrink significantly, with some tumors becoming undetectable. Specifically, 8.2% of patients had no trace of cancer by the end of the study, and more than 76% of participants survived for at…New York Post
20 Nov Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’Doctors are celebrating early results from a trial of a new pill called daraxonrasib for pancreatic cancer, which showed that in one in 12 patients, the cancer became undetectable. In the trial involving 61 patients with advanced cancer that had spread, tumours stopped growing in 90% of cases, and over 60% saw their tumours shrink or disappear. Dr. Wungki Park, who presented the findings at a symposium in Barcelona…The Guardian
20 Nov Massive hope for pancreatic cancer pill after trial saw tumours vanishExperts are heralding a daily pill called daraxonrasib as a major breakthrough in pancreatic cancer treatment, with some patients showing undetectable tumors on scans. In a trial involving 61 recently diagnosed patients with advanced pancreatic cancer, tumors stopped growing in 90% of participants, and for around 8%, or one in 12, tumors became undetectable. While this is considered highly promising, doctors…BBC
Built 2026-11-22 from 4 articles. Every sentence on this page is quoted from the linked article; nothing was written by a model except the Summary and the items marked AI, which cite their sources, and the questions and labels under "Disputed". Photos are from the outlets that covered the story, never from articles our check marks sensitive.